{"name":"Vividion Therapeutics, Inc.","slug":"vividion-therapeutics-inc","ticker":"","exchange":"","domain":"vividion.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"VVD-133214","genericName":"VVD-133214","slug":"vvd-133214","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"VVD-133214","genericName":"VVD-133214","slug":"vvd-133214","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQNUxnRmJOTFExck5lM2Q2OXNfdjJaM0Q0ZUtxSzJrRk9Pc2xFQWE5b2Ztai1wemU5WTZCSHNQdWMtQmU4aDl5cldoakFJdmpuTEFFN2lGWlFaVnE4SGNsRWZFWUdxMkR2ckpCc2hmdURBNkVOVEluZk9ud2VSQUVsZzVWaG4zaTl6Q21vb0xtSE5EcVpIQ2ZQOXNNV0NsbmEwU0NkUVV3?oc=5","date":"2025-11-12","type":"pipeline","source":"Fierce Biotech","summary":"Bayer bails on Vividion tumor drug as part of early-stage cancer clear-out - Fierce Biotech","headline":"Bayer bails on Vividion tumor drug as part of early-stage cancer clear-out","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxPam4tSmhvN2QxQmpuWXNES2l1TTRGd2xsYXAzNUJDZVFWZzhaU2U1QV84YWZ2RHNlSHpUX1JiYVJjNjNnVkZiRTBpNEpGUS1sSE9hZjkzcnFuVkt2ZUV1VVdiMF9kVTFGMXN1SFN1YmNodDVjNkl3a0lmS2FVQmQ3T1pIQzN2LTZtSzdkN0lYT2lvUlVvempqSGdXdWMwTzBEMW1VMTZMbjZ6ZEdMTXFhMlJfZWw0UzI5b2hkT0Y1Tl9lNWQwU1ZrMTk2cmZZcDYt?oc=5","date":"2025-08-13","type":"pipeline","source":"businesswire.com","summary":"Vividion Therapeutics Appoints Sam Whiting, M.D., Ph.D., as Chief Medical Officer - businesswire.com","headline":"Vividion Therapeutics Appoints Sam Whiting, M.D., Ph.D., as Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-06-08","type":"pipeline","source":"Medical Dialogues","summary":"Bayer arm secures exclusive worldwide rights to develop, commercialize clinical-stage WRN Inhibitor - Medical Dialogues","headline":"Bayer arm secures exclusive worldwide rights to develop, commercialize clinical-stage WRN Inhibitor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxOeV9jNExSVlNxbTNaRXptWlphQXJQR3V4ZUR0Y0dqY2tHMVJpenJha1N2R3p6QWYycDVIcFV3ZkE1ak82cEtaZEZwNnJ5V0JnV1BnaW1BU3pQVWlzME9IamVjTVlnSUJLMVJGTkc5ZktqTzhvRHF3b3dwSXRFVU9pTG9ZX2h5X1pvSDJCOXhLWTZCX2hhbk42UlRhaVZUQU5FRlBhR0NudTR6SXRRR3Jnd2t6MEFfZHVnRjk4dzRDb0lsdEZjRU53WDMya00yRmJDcDRLSExnU3BCZFpDdHhZTkp5WnIydk9KSTBWaTlfUWM1ZHhjRHJEUXRfbE1JUTIz?oc=5","date":"2025-06-04","type":"pipeline","source":"businesswire.com","summary":"Vividion Therapeutics and Bayer Further Strengthen Oncology Development Pipeline with Clinical-Stage WRN Inhibitor - businesswire.com","headline":"Vividion Therapeutics and Bayer Further Strengthen Oncology Development Pipeline with Clinical-Stage WRN Inhibitor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1IMXl4dlc2YUhZZDgybWczNnE4cEl6Tk9GU3Z1dEtCQVItRTlEbjhMM0xCSG9BeXFLOFJhb2d3YzQ4Y3dCV3l1cmNZak00VThoVmEw?oc=5","date":"2025-06-04","type":"pipeline","source":"FirstWord Pharma","summary":"Vividion, Bayer reclaim WRN inhibitor from Roche after AACR showing - FirstWord Pharma","headline":"Vividion, Bayer reclaim WRN inhibitor from Roche after AACR showing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxNRy1Yc2dmZFk1bjhwS0pOM1hzbmdXQ3d5UF8zNGtiOV9KRjVqSEhLTW05c0EwTWdmMEdsYTllOFl4X0k2NHJrT09vRGI5VDNwV3h3WGhYV2Juam1tVVdPdFJsUEowVkV2S1pmREp2ZFh3QTBKWkFMRGdoU2ZVWWs3SVRZNUFXaXozMG9lTkdKTWRtX0J3YWtBU3JDU1Iybm5hOWRVdDl6SC1iTlhfN1dEYzBUVWI2WkVUT050U05mN1B2SHlkX0s0ZHk1UkpBUGM2SURXRmYwVkI1dVI5OXplR1dzWjVSQ2cyMW1zNUR2dWtzS3ct?oc=5","date":"2025-01-08","type":"deal","source":"Bayer","summary":"Vividion Therapeutics Acquires Tavros Therapeutics to Expand Functional Genomics Capabilities and Boost Drug Discovery Platform - Bayer","headline":"Vividion Therapeutics Acquires Tavros Therapeutics to Expand Functional Genomics Capabilities and Boost Drug Discovery P","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOd2VTVTN6QU55Tkw0LVNTd3FxbVU3VTc5cWk5T19welFxQmVPZm50WExRTTBfRXk5SWRsYVVkcUEzZmVLNGNfWW50SUlKeUFVSWNhcVNUNmZVQ3c2SE1NaGw0b051RUJkLXZHY1NrM1h2THlrYmF6UlJzVGZVUUs0M1lSTWYtR1VsYVNWQVhwVG82OWluaXdwOGtObjFfMEZzSVFsMTg0Njk?oc=5","date":"2024-08-05","type":"pipeline","source":"San Diego Business Journal","summary":"Vividion Therapeutics Expands with HQ, R&D Center - San Diego Business Journal","headline":"Vividion Therapeutics Expands with HQ, R&D Center","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOTjNUT3MzQW8tTUVQcWpqeHBFNGk4am1DTTh4azUxREhHUGZZYUVNMmpOaEs4RTEzVkF0SHRCTHNUWkZoUks2YTYxTHlaT2t2WllKWkZJcVdtTmozRkFGblU0SW9QeTBqNmxsTUFYdUNDbHN3N19PWHI2UU1mdWlDT0dIYVc3WVhFa0RmQ0hKX0s3NXZpaWdGNHFxcTZ6UzU5OWpRbHdyb0VZN3RFbG1qaE5zSmFCajh1aVpBd3ln?oc=5","date":"2021-08-05","type":"pipeline","source":"Bayer","summary":"Bayer strengthens drug discovery platform through acquisition of Vividion Therapeutics - Bayer","headline":"Bayer strengthens drug discovery platform through acquisition of Vividion Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQY1pLX2RjSWo5YV92aXdSUGFIYlhZV0I1TmN3Qy1RTlYyTnpoUkFDV20zWGJLMUdTTDRNVVBXQTZoaWlrMmlaSGJOMURQc1lMdkc0WUFXdU9EQWxxNVNtOVFZSEVWQXJ5Nzl0Sk9vY01KT0lrLWdnQXhkUW9aLUN2UVk1dTUyWHhvY29mZV9wV1RDZ25jMTZReHBFZk1GbU5iTzNqUHRTU1RMazRYOEhTdmtxZF9lMXFXNHQxZGMzZnJ3Mkk?oc=5","date":"2021-08-05","type":"deal","source":"C&EN","summary":"Bayer acquires small molecule startup Vividion Therapeutics for up to $2 billion - C&EN","headline":"Bayer acquires small molecule startup Vividion Therapeutics for up to $2 billion - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNcWEyQVJtSDNvN1NwcXlUb0VkM2dZTGxMSFk4MzZuQ1d3RUE0aU44MlR4Y25VTnFObkdINVlzOHk2NDE0ejJ2ek1qNDYxMTNSM3VqOVJaSzlDekF0dFlISEJwTzlvLXZBZ01wX05zU2duY0tlS2xkNkR4bC00ZElib29xX2dmSGF4bE9Z?oc=5","date":"2021-08-05","type":"deal","source":"BioPharma Dive","summary":"How Bayer lured a biotech away from an IPO and into a buyout - BioPharma Dive","headline":"How Bayer lured a biotech away from an IPO and into a buyout","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPcXpuQjVUOWMwWUt5MDlrSDVBcnZNTEd2Um9NLWo3ZUdVRnhTc0huNkZmSHU5LXNuR2JNbmJCYVhrZUd1bk9BQzYxcVFOVzJER05WNUphczIzRjdpblJRMjJmcktYTGUxWFB0ZWxGUXlBc0RyUzNjeGk5MnJuV09rLU8zOUFBNVpFTm5RZFJfVV9Ca1AwODFqcDhNdC01dURKRDE3MTVWa1hlN0xDd0E?oc=5","date":"2021-08-05","type":"pipeline","source":"Fierce Biotech","summary":"Bayer bets $1.5B that Vividion will help it target the 'undruggable' and make 1+1=3 - Fierce Biotech","headline":"Bayer bets $1.5B that Vividion will help it target the 'undruggable' and make 1+1=3","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxPUjZTLTFaWVF6Ujc5UmhOZ193T3lCejFFVUdadC0xcnFVZEs3a1A3RXVWT0lkd3V5OUVaSmZIRkJGNGtQSXJ5dHpuWkRoT1dGN2JKSGMwSEZnYjlMX0ZEcW16bEdzMHpSQnF5XzZtQTRpeHktZENHaGhuZURLU2ZRSlo4NC04d3EteFpJWVRuNVEzTzFZUDdMUWVBb3h0a3ZENl8yeWRZakViMnNtMTJ6cW9zZklsUWc4LW1rSnh6YUpaM01HS1hGTVZTcWp4VWRUU1hWUGd3X19kakoycXdFQTFRR2I5Q1JNYTA0?oc=5","date":"2020-05-19","type":"deal","source":"prnewswire.com","summary":"Vividion Therapeutics Announces Drug Discovery Collaboration with Roche Focused on Novel E3 Ligases - prnewswire.com","headline":"Vividion Therapeutics Announces Drug Discovery Collaboration with Roche Focused on Novel E3 Ligases","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}